These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8718332)

  • 21. [Present and future of trial design].
    Vargas Vorácková F
    Rev Invest Clin; 1990 Jul; 42 Suppl():36-8. PubMed ID: 19256131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical limit to trials needed in one-person randomized controlled experiments.
    Alemi R; Alemi F
    Qual Manag Health Care; 2007; 16(2):130-4. PubMed ID: 17426611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designs for efficient clinical trials.
    Simon R
    Oncology (Williston Park); 1989 Jul; 3(7):43-9; discussion 51-3. PubMed ID: 2701811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
    Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
    Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How first-time-in-human studies are being performed: a survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004.
    Buoen C; Bjerrum OJ; Thomsen MS
    J Clin Pharmacol; 2005 Oct; 45(10):1123-36. PubMed ID: 16172177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant.
    Mallinckrodt C; Chuang-Stein C; McSorley P; Schwartz J; Archibald DG; Perahia DG; Detke MJ; Alphs L
    Pharm Stat; 2007; 6(1):9-22. PubMed ID: 17238129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of paired ordered categorical data in a factorial design.
    Patel HI; Tsai KT
    J Biopharm Stat; 1996 Mar; 6(1):15-36. PubMed ID: 8838776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical trials: principles of the method].
    Aboulker JP
    Rev Prat; 2000 Apr; 50(8):829-32. PubMed ID: 10874858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis.
    Lega JC; Mismetti P; Cucherat M; Fassier T; Bertoletti L; Chapelle C; Laporte S
    J Thromb Haemost; 2013 Jul; 11(7):1240-50. PubMed ID: 23659614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statistical process control in nursing research.
    Polit DF; Chaboyer W
    Res Nurs Health; 2012 Feb; 35(1):82-93. PubMed ID: 22095634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing Clinical Research Using Factorial Designs: A Primer.
    Baker TB; Smith SS; Bolt DM; Loh WY; Mermelstein R; Fiore MC; Piper ME; Collins LM
    Behav Ther; 2017 Jul; 48(4):567-580. PubMed ID: 28577591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Critical analysis of types and objectives of phamacological trials].
    Juhos V
    Ideggyogy Sz; 2011 Sep; 64(9-10):325-7. PubMed ID: 22059369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized phase II designs in cancer clinical trials: current status and future directions.
    Lee JJ; Feng L
    J Clin Oncol; 2005 Jul; 23(19):4450-7. PubMed ID: 15994154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factorial designs: an overview with applications to orthodontic clinical trials.
    Pandis N; Walsh T; Polychronopoulou A; Katsaros C; Eliades T
    Eur J Orthod; 2014 Jun; 36(3):314-20. PubMed ID: 23885023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do we know what we know? The randomized controlled trial revisited.
    Heaney RP
    J Bone Miner Res; 1991 Feb; 6(2):103-5. PubMed ID: 2028831
    [No Abstract]   [Full Text] [Related]  

  • 38. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific evidence and emotional care.
    Casey A
    Paediatr Nurs; 1999 Jul; 11(6):3. PubMed ID: 10595159
    [No Abstract]   [Full Text] [Related]  

  • 40. Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research.
    Rains JC; Penzien DB
    Headache; 2005 May; 45(5):479-86. PubMed ID: 15953264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.